These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 3930017)
1. Transfusion therapy for patients with cancer. Lichtiger B; Huh YO CA Cancer J Clin; 1985; 35(5):311-6. PubMed ID: 3930017 [No Abstract] [Full Text] [Related]
2. [Indications for blood transfusion]. Khollan SR Gematol Transfuziol; 1989 Aug; 34(8):47-53. PubMed ID: 2511059 [No Abstract] [Full Text] [Related]
4. Recent advances in the practice and technology of blood transfusion. Sandler SG Prim Care; 1980 Sep; 7(3):347-67. PubMed ID: 6777791 [No Abstract] [Full Text] [Related]
5. Optimal use of blood components and derivatives. Walter WJ; Oberman HA Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570 [No Abstract] [Full Text] [Related]
6. [Indications for blood transfusion]. Hollán Z Ter Arkh; 1989; 61(7):113-21. PubMed ID: 2511636 [No Abstract] [Full Text] [Related]
7. Transfusion support for leukaemia and oncology patients. Mayer K Clin Haematol; 1984 Feb; 13(1):93-8. PubMed ID: 6373084 [No Abstract] [Full Text] [Related]
8. Evidence for plasma-mediated immunomodulation--transfusions of plasma-rich blood components are associated with a greater risk of acquired immunodeficiency syndrome than transfusions of red blood cells alone. Blumberg N; Heal JM Transplant Proc; 1988 Dec; 20(6):1138-42. PubMed ID: 3144070 [No Abstract] [Full Text] [Related]
9. Platelet and granulocyte transfusions in cancer patients. Dutcher JP Adv Immun Cancer Ther; 1986; 2():211-49. PubMed ID: 3321947 [No Abstract] [Full Text] [Related]
10. Blood component therapy in the perinatal period: guidelines and recommendations. DePalma L; Luban NL Semin Perinatol; 1990 Oct; 14(5):403-15. PubMed ID: 2126893 [No Abstract] [Full Text] [Related]
11. Blood products. Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967 [No Abstract] [Full Text] [Related]
15. Pediatric transfusion: considerations by age and blood component. Glassman AB South Med J; 1982 Jun; 75(6):722-5. PubMed ID: 6806910 [TBL] [Abstract][Full Text] [Related]
17. [Cellular blood substitutes]. Z Gesamte Inn Med; 1979 Nov; 34(21):suppl 300-4. PubMed ID: 550615 [No Abstract] [Full Text] [Related]
18. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Mozes B; Epstein M; Ben-Bassat I; Modan B; Halkin H Transfusion; 1989; 29(6):473-6. PubMed ID: 2501916 [TBL] [Abstract][Full Text] [Related]
19. Blood transfusion reactions. Shafer N; Wilkenfeld M; Shafer R Leg Med; 1980; ():207-20. PubMed ID: 7421388 [TBL] [Abstract][Full Text] [Related]
20. The chronically transfused patient: advances in treatment. McCullough J; Jacob HS Hosp Pract (Off Ed); 1985 Jul; 20(7):77-84. PubMed ID: 3924941 [No Abstract] [Full Text] [Related] [Next] [New Search]